Skip to main content

Videos

Why Health Plans, Systems Should Work Together to Improve Care for Vulnerable Populations
Videos
10/08/2020
Jacob Sattelmair, CEO of Wellframe, a market-leading digital health management company, discusses the COVID-19 Chronic Condition Population Report and highlights how the findings help provide both health plans and health care organizations...
Jacob Sattelmair, CEO of Wellframe, a market-leading digital health management company, discusses the COVID-19 Chronic Condition Population Report and highlights how the findings help provide both health plans and health care organizations...
Jacob Sattelmair, CEO of...
10/08/2020
First Report Managed Care
Panel: Understanding the Use of Predictive Modeling to Track the Pandemic Spread and Associated Diagnostics
Videos
09/30/2020
Scott Collins, president, Aria Marketing, leads a discussion with Ron Chiarello, PhD, founder and CEO, Alveo Technologies, and Emad Rizk, MD, president and CEO, Cotiviti, about the current state of health care and how health care systems are...
Scott Collins, president, Aria Marketing, leads a discussion with Ron Chiarello, PhD, founder and CEO, Alveo Technologies, and Emad Rizk, MD, president and CEO, Cotiviti, about the current state of health care and how health care systems are...
Scott Collins, president, Aria...
09/30/2020
First Report Managed Care
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
Videos
09/23/2020
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of...
09/23/2020
First Report Managed Care
Improving Survival, Remission Rates Among Patients With AML Treated With New Drug Combo
Videos
07/08/2020
Keith Pratz, MD, associate professor of medicine at the Abramson Comprehensive Cancer Center at University of Pennsylvania, discusses the phase III VIALE-A study that demonstrated a reduction in the risk of death in patients with AML among...
Keith Pratz, MD, associate professor of medicine at the Abramson Comprehensive Cancer Center at University of Pennsylvania, discusses the phase III VIALE-A study that demonstrated a reduction in the risk of death in patients with AML among...
Keith Pratz, MD, associate...
07/08/2020
First Report Managed Care
Improving Survival Rates Among Patients With NSCLC Using New, Effective Treatment Strategy
Videos
06/18/2020
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign...
06/18/2020
First Report Managed Care
Providing the Most for Medicare Advantage Members Amid Pandemic
Videos
06/12/2020
Betsy Seals, principal consultant and founder, and Debra Devereaux, MBA, RPh, principal consultant and founder, both from the Rebellis Group, a managed care consulting firm, discuss actions taken by national players in the wake of COVID-19,...
Betsy Seals, principal consultant and founder, and Debra Devereaux, MBA, RPh, principal consultant and founder, both from the Rebellis Group, a managed care consulting firm, discuss actions taken by national players in the wake of COVID-19,...
Betsy Seals, principal...
06/12/2020
First Report Managed Care
Understanding Response Time for Patients With AML Using Drug Treatment Combo
Videos
06/02/2020
Brian Jonas, MD, PhD, associate professor of medicine at the University of California at Davis School of Medicine and UC Davis Comprehensive Cancer Center, discusses recent data presented at ASCO 2020, including use of combination therapy...
Brian Jonas, MD, PhD, associate professor of medicine at the University of California at Davis School of Medicine and UC Davis Comprehensive Cancer Center, discusses recent data presented at ASCO 2020, including use of combination therapy...
Brian Jonas, MD, PhD, associate...
06/02/2020
First Report Managed Care
Follow-Up Study Demonstrates Long-Term Treatment Benefits for Patients With CLL
Videos
06/02/2020
Othman Al-Sawaf, MD, hematologist-oncologist at the University Hospital Cologne, Cologne, Germany, and study physician at the German CLL Study Group, discusses his recent study and highlights why treatment with venetoclax-obinutuzumab...
Othman Al-Sawaf, MD, hematologist-oncologist at the University Hospital Cologne, Cologne, Germany, and study physician at the German CLL Study Group, discusses his recent study and highlights why treatment with venetoclax-obinutuzumab...
Othman Al-Sawaf, MD,...
06/02/2020
First Report Managed Care
Breaking Down the Positive Findings of Phase III Trial for Prostate Cancer Drug
Videos
06/01/2020
Mark Wildgust, PhD, vice president, medical affairs/oncology, Janssen, discusses the results of the SPARTAN study that examined use of Erleada (apalutamide) for the treatment of prostate cancer, and highlights how the findings of this study...
Mark Wildgust, PhD, vice president, medical affairs/oncology, Janssen, discusses the results of the SPARTAN study that examined use of Erleada (apalutamide) for the treatment of prostate cancer, and highlights how the findings of this study...
Mark Wildgust, PhD, vice...
06/01/2020
First Report Managed Care
Understanding Indications, Tailoring Therapy Options for CLL Patients
Videos
05/18/2020
Benyam Muluneh, PharmD, assistant professor, UNC Eshelman School of Pharmacy, and Katie Buhlinger, PharmD, CPP, clinical pharmacist practitioner, UNC Medical Center, discuss the benefits and complications associated with ibrutinib treatment...
Benyam Muluneh, PharmD, assistant professor, UNC Eshelman School of Pharmacy, and Katie Buhlinger, PharmD, CPP, clinical pharmacist practitioner, UNC Medical Center, discuss the benefits and complications associated with ibrutinib treatment...
Benyam Muluneh, PharmD,...
05/18/2020
First Report Managed Care